1. Home
  2. QTTB vs CULP Comparison

QTTB vs CULP Comparison

Compare QTTB & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.37

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$2.72

Market Cap

43.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
CULP
Founded
2015
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
43.8M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
QTTB
CULP
Price
$6.37
$2.72
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
349.4K
38.4K
Earning Date
05-07-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
136.78
N/A
EPS
2.42
N/A
Revenue
$53,737,000.00
$213,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.42
P/E Ratio
$2.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$2.70
52 Week High
$8.05
$4.75

Technical Indicators

Market Signals
Indicator
QTTB
CULP
Relative Strength Index (RSI) 54.11 28.25
Support Level $3.49 N/A
Resistance Level $7.80 $3.60
Average True Range (ATR) 0.93 0.17
MACD -0.13 0.00
Stochastic Oscillator 34.32 2.17

Price Performance

Historical Comparison
QTTB
CULP

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: